股票 › HALO
哈洛泽生物 HALO
美股市值排名 #1314
$103.63 −$19.33 (-15.72%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $103.75 +0.12%
开盘$117.03
昨收$122.96
当日区间$102.52 – $118.26
成交量6.16M
市值$11.81B
市盈率（TTM）25.9
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例111.9%+1.79 个百分点，较上季度
持仓机构数854+52 ，较上季度
内部人近期交易26次买入 / 24次卖出净买入
空头持仓比例12.03% 占流通股回补天数 6.2 · 截至 15 Oct 2026
卖空成交量占比13.7%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$28.69M（12个净流入日，8个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有28.8%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从11.82%升至12.03%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Distillate Capital Partners LLC | Mutual Fund | 2026/Q3 | +149,323 | 0.1% |
| Congress Asset Management Company, LLP | Mutual Fund | 2026/Q3 | +1,052,509 | 2.0% |
| Wasatch Advisors LP | Mutual Fund | 2026/Q3 | +1,049,647 | 0.9% |
| Citigroup Inc. | Public Company | 2026/Q3 | +190,549 | 0.5% |
| Context Capital Management LLC | Hedge Fund | 2026/Q3 | +139,811 | 0.1% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q3 | +1,248,120 | 1.7% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +976,321 | 0.9% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +507,932 | 0.8% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +406,662 | 1.6% |
| WEDGE Capital Management LLP | Mutual Fund | 2026/Q3 | +403,824 | 0.4% |
| Boston Trust Walden National Association | Mutual Fund | 2026/Q3 | +403,499 | 1.0% |
| Frontier Capital Management | Mutual Fund | 2026/Q3 | +342,570 | 0.3% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +281,210 | 0.5% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +241,580 | 4.6% |
| Neuberger Berman Investment Advisers LLC | Mutual Fund | 2026/Q3 | +240,442 | 0.2% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 7 Oct 2026 | Helen Torley | Chief Executive Officer | Derivative Exercise and Sale | -60,000 | $113.69 | 767,780 |
| 30 Sep 2026 | James Daly | Director | Other Acquisition | +1,169 | – | 1,169 |
| 30 Sep 2026 | James Daly | Director | Other Derivative Acquisition | +1,775 | $106.94 | 1,775 |
| 30 Sep 2026 | Matthew Posard | Independent Director | Automatic Disposition | -5,230 | $110.04 | 49,813 |
| 15 Sep 2026 | Matthew Posard | Independent Director | Automatic Disposition | -18,996 | $108.99 | 55,043 |
| 10 Sep 2026 | Helen Torley | Chief Executive Officer | Derivative Exercise and Sale | -60,000 | $108.67 | 767,780 |
| 31 Aug 2026 | Dannielle Appelhans | Director | Other Acquisition | +1,161 | – | 1,161 |
| 31 Aug 2026 | Dannielle Appelhans | Director | Other Derivative Acquisition | +1,778 | $107.72 | 1,778 |
| 18 Aug 2026 | Helen Torley | Chief Executive Officer | Derivative Exercise and Sale | -60,000 | $107.77 | 767,780 |
| 9 Aug 2026 | Bernadette Connaughton | Independent Director | Automatic Disposition | -1,626 | $102.80 | 33,622 |
| 7 Jul 2026 | Helen Torley | Chief Executive Officer | Derivative Exercise and Sale | -1,923 | $80.19 | 767,780 |
| 30 Jun 2026 | David Ramsay | President of Drug Delivery | Other Derivative Acquisition | +16,232 | – | 16,232 |
| 30 Jun 2026 | David Ramsay | President of Drug Delivery | Other Derivative Acquisition | +39,823 | $77.01 | 39,823 |
| 30 Jun 2026 | Bernadette Connaughton | Independent Director | Automatic Disposition | -1,625 | $77.21 | 35,248 |
| 30 Jun 2026 | Darren Snellgrove | Senior Vice President | Other Derivative Acquisition | +41,554 | – | 41,554 |
| 30 Jun 2026 | Darren Snellgrove | Senior Vice President | Other Derivative Acquisition | +127,432 | $77.01 | 127,432 |
| 29 Jun 2026 | David Ramsay | President of Drug Delivery | Derivative Exercise and Sale | -5,408 | $78.27 | 4,592 |
| 29 Jun 2026 | David Ramsay | President of Drug Delivery | Derivative Exercise and Retained | +4,592 | – | 4,592 |
| 28 Jun 2026 | Mahesh Krishnan | Independent Director | Derivative Exercise and Sale | -7,304 | $75.00 | 10,666 |
| 11 Jun 2026 | Mark Snyder | Executive VP, General Counsel, Chief Compliance Officer & Corporate Secretary | Derivative Exercise and Sale | -2,715 | $69.50 | 49,929 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 13,654,228 | 12.0% | 6.2 |
| 30 Sep 2026 | 15,295,841 | 13.5% | 4.5 |
| 15 Sep 2026 | 15,154,414 | 13.4% | 11.6 |
| 31 Aug 2026 | 14,880,707 | 13.1% | 8.7 |
| 14 Aug 2026 | 14,636,927 | 12.9% | 5.0 |
| 31 Jul 2026 | 14,022,134 | 11.8% | 8.4 |
暂无评论——快来第一个聊聊 HALO。
登录后参与讨论。